Literature DB >> 9369886

Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease.

W K Kauer1, J H Peters, T R DeMeester, H Feussner, A P Ireland, H J Stein, R J Siewert.   

Abstract

BACKGROUND: Reflux of duodenal contents into the esophagus of patients with gastroesophageal reflux disease has been suggested by pH and bilirubin monitoring but is rarely directly measured. A portable device has been developed and was used to collect and quantitate material refluxed into the esophagus under ambulatory conditions during a prolonged time period. The objective of this study was to use this device to quantitate the composition and concentration of bile acids refluxed into the esophagus of patients with gastroesophageal reflux disease.
METHODS: Esophageal aspiration was performed on 43 normal subjects and 37 patients with reflux disease during a 17-hour period. Aspiration was performed through a modified 16F Salem sump tube, positioned 5 cm above the lower esophageal sphincter and connected to a portable, battery powered pump that aspirated continuously at 100 mm Hg pressure. Validation studies showed that minimal amounts of saliva and swallowed liquids were aspirated and that gastric pressure was not altered. Postprandial, upright, and supine collections were performed. Total bile acids were assayed by a standard enzymatic assay; specific conjugated bile acids were analyzed by high-performance liquid chromatography.
RESULTS: There was no difference in the total aspiration volume between normal volunteers and patients with gastroesophageal reflux disease, although patients tended to have a higher volume in the supine and postprandial periods. Bile acids could be detected in 58% of normal subjects and 86% of patients (p < 0.003). The mean concentration of bile salt exposure (micromole per liter) was higher in patients during the postprandial and supine periods. The mean bile acid reflux rate (micromole per hour) during all three aspiration periods was significantly higher in patients. On a molar basis the composition of the bile acids was 60% glycocholic acid, 16% glycodeoxycholic acid, and 15% glycochenodeoxycholic acid. Taurocholic, taurodeoxycholic, taurochenodeoxycholic, and glycolithocholic acid constituted the remaining 10%.
CONCLUSIONS: Patients with reflux disease have an increased concentration of bile acids in their esophageal aspirates. Most of the exposure occurs during the postprandial and supine periods. A variety of bile acids were detected, most of which were in their glycine conjugated form.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369886     DOI: 10.1016/s0039-6060(97)90327-5

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  68 in total

1.  Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.

Authors:  Xiaofang Huo; Stefanie Juergens; Xi Zhang; Davood Rezaei; Chunhua Yu; Eric D Strauch; Jian-Ying Wang; Edaire Cheng; Frank Meyer; David H Wang; Qiuyang Zhang; Stuart J Spechler; Rhonda F Souza
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-02       Impact factor: 4.052

2.  Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia.

Authors:  Michael Quante; Govind Bhagat; Julian A Abrams; Frederic Marache; Pamela Good; Michele D Lee; Yoomi Lee; Richard Friedman; Samuel Asfaha; Zinaida Dubeykovskaya; Umar Mahmood; Jose-Luiz Figueiredo; Jan Kitajewski; Carrie Shawber; Charles J Lightdale; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

3.  Morbidity and mortality results from a prospective randomized controlled trial comparing Billroth I and Roux-en-Y reconstructive procedures after distal gastrectomy for gastric cancer.

Authors:  Hiroshi Imamura; Shuji Takiguchi; Kazuyoshi Yamamoto; Motohiro Hirao; Junya Fujita; Isao Miyashiro; Yukinori Kurokawa; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

4.  Long-term outcomes of Roux-en-Y and Billroth-I reconstruction after laparoscopic distal gastrectomy.

Authors:  Mikito Inokuchi; Kazuyuki Kojima; Hiroyuki Yamada; Keiji Kato; Mikiko Hayashi; Kazuo Motoyama; Kenichi Sugihara
Journal:  Gastric Cancer       Date:  2012-03-31       Impact factor: 7.370

5.  A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT.

Authors:  Shuji Takiguchi; Kazuyoshi Yamamoto; Motohiro Hirao; Hiroshi Imamura; Junya Fujita; Masahiko Yano; Kenji Kobayashi; Yutaka Kimura; Yukinori Kurokawa; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2011-10-13       Impact factor: 7.370

6.  Bile Salts at Low pH Cause Dilation of Intercellular Spaces in In Vitro Stratified Primary Esophageal Cells, Possibly by Modulating Wnt Signaling.

Authors:  Sayak Ghatak; Marie Reveiller; Liana Toia; Andrei I Ivanov; Zhongren Zhou; Eileen M Redmond; Tony E Godfrey; Jeffrey H Peters
Journal:  J Gastrointest Surg       Date:  2015-12-29       Impact factor: 3.452

7.  Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katerina Dvorak; George S Watts; Lois Ramsey; Hana Holubec; Claire M Payne; Carol Bernstein; Gareth J Jenkins; Richard E Sampliner; Anil Prasad; Harinder S Garewal; Harris Bernstein
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

8.  In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1.

Authors:  Xiaofang Huo; Xi Zhang; Chunhua Yu; Qiuyang Zhang; Edaire Cheng; David H Wang; Thai H Pham; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2013-09-18       Impact factor: 23.059

9.  Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway.

Authors:  Shumei Song; James C Byrd; Sushovan Guha; Kai-Feng Liu; Dimpy Koul; Robert S Bresalier
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

10.  Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD.

Authors:  Xiaofang Huo; Agoston T Agoston; Kerry B Dunbar; Daisha J Cipher; Xi Zhang; Chunhua Yu; Edaire Cheng; Qiuyang Zhang; Thai H Pham; Uttam K Tambar; Richard K Bruick; David H Wang; Robert D Odze; Stuart J Spechler; Rhonda F Souza
Journal:  Gut       Date:  2016-09-30       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.